KHC-4 anti-cancer effects on human PC3 prostate cancer cell line

American Journal of Chinese Medicine

Volumn 40, Issue 5, 2012, Pages 1063-1071

  Hwang, Jin Ming ^a   Ting, Wei Jen ^b   Wu, Hsi Chin ^c   Chen, Yi Jyun ^b   Tsai, Fu Jenn ^b   Chen, Po Yuan ^b   Liu, Chin Yu ^b   Chou, Li Chen ^b   Kuo, Sheng Chu ^b   Huang, Chih Yang ^b,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Anti proliferation; Apoptosis; KHC 4; PC3

Indexed keywords

2 PHENYL 4 QUINOLONE DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; GELATINASE A; KHC 4; PROCASPASE 9; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IC 50; MALE; METASTASIS; PROSTATE CANCER; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CASPASE 9; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN B1; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MORPHOLINES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; QUINOLONES;

EID: 84865777498     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X12500784     Document Type: Article

References (22)

1. Andreasen, P. A., L. Kjoller, L. Christensen and M. J. Duffy. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72:1-22, 1997.
2. Chae, H. D., J. Kim and D. Y. Shin. NF-Y binds to both G1-and G2-specific cyclin promoters; a possible role in linking CDK2/Cyclin A to CDK1/Cyclin B. BMB Reports 44:553-557, 2011.
3. Chen, Y. C., P. H. Lu, S. L. Pan, C. M. Teng, S. C. Kuo, T. P. Lin, Y. F. Ho, Y. C. Huang and J. H. Guh. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways. Biochem. Pharmacol. 74:10-19, 2007.
4. Dharap, S. S., P. Chandna, Y. Wang, J. J. Khandare, B. Qiu, S. Stein and T. Minko. Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy. J. Pharmacol. Exp. Ther. 316:992-998, 2006.
5. Du, R. H., J. T. Cui, T. Wang, A. H. Zhang and R. X. Tan. Trichothecin induces apoptosis of HepG2 cells via caspase-9 mediated activation of the mitochondrial death pathway. Toxicon 59:143-150, 2012.
6. Fu, W., E. Madan, M. Yee and H. Zhang. Progress of molecular targeted therapies for prostate cancers. Biochim. Biophys. Acta 1825:140-152, 2011.
7. Greenlee, R. T., M. B. Hill-Harmon, T. Murray and M. Thun. Cancer statistics, 2001. CA Cancer J. Clin. 51:15-36, 2001.
8. Gu, X., X. Fu, Y. Yang, T. Sun and L. Jiang. Expression characteristics of c-fos, c-myc and bFGF in early burn tissue. Chin. Med. J. 114:925-928, 2001.
9. Hadjeri, M., E. L. Peiller, C. Beney, N. Dekam, M. A. Lawson, C. Dumontet and A. Boumendjel. Antimitotic activity of 5-hydroxy-7-methoxy-2-phenyl-4- quinolones. J. Med. Chem. 47:4964-4970. 2004.
10. Hsu, S. C., J. S. Yang, C. L. Kuo, C. Lo, J. P. Lin, T. C. Hsia, J. J. Lin, K. C. Lai, H. M. Kuo, L. J. Huang, S. C. Kuo, W. G. Wood and J. G. Chung. Novel quinolone CHM-1 induces apoptosis and inhibits metastasis in a human osterogenic sarcoma cell line. J. Orthop. Res. 27:1637-1644, 2009.
11. Huang, L. J., M. C. Hsieh, C. M. Teng, K. H. Lee and S. C. Kuo. Synthesis and anti-platelet activity of phenyl quinolones. Bioorg. Med. Chem. 6:1657-1662, 1998.
12. Justman, S. What's wrong with chemoprevention of prostate cancer? Am. J. Bioeth. 11:21-25, 2011.
13. Kõivomägi, M., E. Valk, R. Venta, A. Iofik, M. Lepiku, D. O. Morgan and M. Loog. Dynamics of Cdk1 substrate specificity during the cell cycle. Mol. Cell 42:610-623, 2011.
14. Kuo, S. C., H. Z. Lee, J. P. Juang, Y. T. Lin, T. S. Wu, J. J. Chang, D. Lednicer, K. D. Paull and C. M. Lin. Synthesis and cytotoxicity of 1, 6, 7, 8-substituted 2-(4'-substituted phenyl)-4-quinolones and related compounds: identification as anti-mitotic agents interacting with tubulin. J. Med. Chem. 36:1146-1156, 1993.
15. Lee, J. C., L. C. Chou, C. H. Huang, J. G. Chung, L. J. Huang, K. H. Lee, M. C. Hung, T. D. Way and S. C. Kuo. CHM-1 induces apoptosis via p38-mediated up-regulation of DR5 expression in human ovarian cancer SKOV3 cells. Eur. J. Pharm. 670:96-104, 2011.
16. Li, L., H. K. Wang, S. C. Kuo, T. S. Wu. D. Lednicer, C. M. Lin, E. Hamel and K. H. Lee. Antitumor agents. 150. 2', 3', 4', 5', 5, 6, 7-substituted 2-phenyl-4-quinolones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J. Med. Chem. 37:1126-1135, 1994.
17. Margolis, R. L. and L. Wilson. Micro-tubule tread milling: what goes around comes around. Bioessays 20:830-836, 1998.
18. Wang, L. G., X. M. Liu, W. Kreis and D. R. Budman. The effect of anti-micro-tubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother. Pharmacol. 44:355-361, 1999.
19. Wang, S. W., S. L. Pan, Y. C. Huang, J. H. Guh, P. C. Chiang, D. Y. Huang, S. C. Kuo, K. H. Lee and C. M. Teng. CHM-1, a novel synthetic quinolone with potent and selective anti-mitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo. Mol. Cancer Ther. 7:350-360, 2008.
20. Xia, Y., Z. Y. Yang, P. Xia, K. F. Bastow, Y. Tachibana, S. C. Kuo, E. Hamel, T. Hackl and K. H. Lee. Antitumor agents. 181. Synthesis and biological evaluation of 6, 7, 2', 3', 4'-substituted-1, 2, 3, 4-tetrahydro-2-phenyl-4- quinolones as a new class of anti-mitotic antitumor agents. J. Med. Chem. 41:1155-1162. 1998.
21. Xia, Y., Z. Y. Yang, P. Xia, T. Hackl, E. Hamel, A. Mauger, J. H. Wu and K. H. Lee. Antitumor Agents. 211. Fluorinated 2-phenyl-4-quinolone derivatives as anti-mitotic antitumor agents. J. Med. Chem. 44:3932-3926, 2001.
22. Xia, Y., Z. Y. Yang, P. Xia, K. F. Bastow, Y. Nakanishi, P. Nampoothiri, E. Hamel, A. Brossi and K. H. Lee. Antitumor agents. Part 226: synthesis and cytotoxicity of 2-phenyl-4-quinolone acetic acids and their esters. Bioorg. Med. Chem. Lett. 13:2891-2893, 2003.